CTXR Stock Analysis: Buy, Sell, or Hold?
CTXR - Citius Pharmaceuticals Inc. Common
$0.85
0.01 (1.32%)
▲
5d:
+23.05%
30d:
+4.63%
90d:
+9.94%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
CTXR is down 13.1% this week, but smart money is accumulating calls. Top strike: $1 2026-05-15 with 1,248 OI. Call ratio: 99% View Scanner →
Strength: 10.0/10
Get Alerted When CTXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CTXR shows positive signals but monitor for confirmation. Market pricing in 3.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CTXR shows positive signals but monitor for confirmation. Market pricing in 3.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.01
15.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CTXR is currently trading at $0.85, which is considered extended relative to its 30-day fair value range of $0.71 to $0.88. The stock's valuation (Forward PE: 0.3) is in line with its historical norms (0.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CTXR is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.94.
Market Sentiment: CTXR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+602.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTXR is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.94.
Market Sentiment: CTXR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+602.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.71 -
$0.88
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 602.4% below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$0.71 -
$0.88
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$0.94
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.31
Wall Street Target
$6.00
(+602.4%)
Valuation Discount vs History
-3.6% cheaper
PE vs Historical
0.3 vs 0.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.6%
(market-implied from PE analysis)
1-Year Target
$0.82
(-4%)
2-Year Target
$0.79
(-7%)
3-Year Target
$0.77
(-10%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
PE COMPRESSION
$0.75
(-12%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 68.1%)
$193.69
(+22575%)
Base:
(SPY PE: 0.3, Growth: 68.1%)
$2.88
(+238%)
Bear:
(PE: 0.3, Growth: 68.1%)
$2.45
(+187%)
Share & Embed Analysis
Last updated: April 02, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTXR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 60 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$100 | 59 HOLD |
